Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Avalo Therapeutics Inc (AVTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Avalo Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
15.503 +0.523    +3.49%
10:15:42 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 13,931
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 15.000 - 15.880
Avalo Therapeutics 15.503 +0.523 +3.49%

AVTX Recent Sentiments

 
This page contains information on users’ sentiments for the Avalo Therapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 24, 2024 DANIEL JOBAJURIA   13.710 +13.08%
Apr 22, 2024 Ergun erg1907   12.580 +23.24%
Apr 16, 2024 Ana Marin   17.360 -10.70%
Apr 11, 2024 Aderson Isaac   16.180 -4.18%
Apr 09, 2024 Filippo Zbogar   13.263 Apr 15, 2024 @ 15.200 +14.60%
Apr 09, 2024 Guilman   14.430 -7.44%
Apr 08, 2024 Felix Salan De Castro   14.210 Apr 15, 2024 @ 15.200 -6.97%
Apr 08, 2024 Taylan Damla   14.810 Apr 15, 2024 @ 15.200 -2.63%
Apr 04, 2024 Attilio Ramaioli   19.760 +21.54%
Apr 04, 2024 Refat Jawabri   17.540 -11.61%
Apr 04, 2024 Koray sarı   17.385 Apr 08, 2024 @ 15.810 -9.06%
Apr 03, 2024 Naif555 Almutairy   16.310 +4.95%
Apr 03, 2024 Mehmet Emin...   16.635 Apr 03, 2024 @ 16.310 +1.95%
Apr 03, 2024 אילן טלר   16.475 -5.90%
Apr 03, 2024 Mohamed Mostafa   16.030 Apr 26, 2024 @ 14.980 -6.55%
Apr 02, 2024 Samuel Gáll   15.325 +1.16%
Apr 02, 2024 Piero Santoro   15.370 Apr 02, 2024 @ 15.160 +1.37%
Apr 02, 2024 Mehmet Emin...   15.015 Apr 02, 2024 @ 15.160 -0.97%
Apr 01, 2024 Piero Santoro   17.340 Apr 02, 2024 @ 15.370 +11.36%
Apr 01, 2024 Suhaib Odeh   16.850 -7.99%
Apr 01, 2024 فارس سلامان   16.681 -7.06%
Apr 01, 2024 Gina Palladino   18.510 Apr 08, 2024 @ 15.810 -14.59%
Apr 01, 2024 Mehmet Emin...   18.500 Apr 01, 2024 @ 17.900 -3.24%
Apr 01, 2024 יאיר אימרגרין   20.210 Apr 01, 2024 @ 16.518 +18.27%
Apr 01, 2024 Елена Междоян   20.210 Apr 01, 2024 @ 16.518 +18.27%
Apr 01, 2024 Benny Matiko   20.210 Apr 01, 2024 @ 16.518 -18.27%
Mar 30, 2024 Filippo Zbogar   20.000 Apr 01, 2024 @ 16.518 +17.41%
Mar 30, 2024 yayla dinler   20.000 Apr 01, 2024 @ 16.518 -17.41%
Mar 29, 2024 tuğçe altıntepe   20.210 Apr 01, 2024 @ 16.518 -18.27%
Mar 28, 2024 Алексей Шапка   26.415 Apr 19, 2024 @ 11.630 -55.97%
Mar 28, 2024 Alimzhan Zhaparov   30.520 Apr 19, 2024 @ 11.630 -61.89%
Mar 28, 2024 Ramazan Uğurlu   22.230 Apr 06, 2024 @ 16.400 -26.23%
Mar 28, 2024 Ramazan Uğurlu   20.820 Mar 28, 2024 @ 20.874 +0.26%
Mar 28, 2024 ahmad alhazmi   21.150 Apr 19, 2024 @ 11.630 -45.01%
Mar 28, 2024 francesco maradei   22.740 Apr 19, 2024 @ 11.630 -48.86%
Mar 28, 2024 Aslan Ortaç   22.525 Apr 19, 2024 @ 11.630 -48.37%
Mar 28, 2024 Özge Nur   22.580 Apr 01, 2024 @ 16.518 -26.85%
Mar 28, 2024 Kaan adanalı Kaan   21.559 Apr 19, 2024 @ 11.630 -46.06%
Mar 28, 2024 Mehmet Emin...   20.223 Mar 31, 2024 @ 21.750 -7.55%
Mar 28, 2024 משה מוסקל   21.210 Apr 01, 2024 @ 16.518 -22.12%
Mar 28, 2024 ro cha   23.950 Apr 19, 2024 @ 11.630 -51.44%
Mar 28, 2024 Angelo Esposito   23.260 Apr 19, 2024 @ 11.630 -50.00%
Mar 28, 2024 Ahmet COPPER   25.895 Apr 01, 2024 @ 16.518 +36.21%
Mar 28, 2024 Sharif Alyafi   24.756 Apr 19, 2024 @ 11.630 -53.02%
Mar 28, 2024 Francisco Gonzalez...   26.268 Apr 19, 2024 @ 11.630 -55.73%
Mar 28, 2024 Oğuzhan Karabay   22.780 Apr 19, 2024 @ 11.630 -48.95%
Mar 28, 2024 Sayed Gomaa El Atafy   24.250 Apr 19, 2024 @ 11.630 -52.04%
Mar 28, 2024 Niyazi Özkan   17.220 Apr 19, 2024 @ 11.630 +32.46%
Mar 28, 2024 Ymer franca   17.000 Mar 28, 2024 @ 4.750 +72.06%
Mar 20, 2024 승환 조   4.460 Apr 12, 2024 @ 14.900 -234.08%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AVTX Comments

Write your thoughts about Avalo Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rowena Amene farkas
Rowena Amene farkas Mar 29, 2024 10:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ranged
Pepe Vega
Pepe Vega Mar 27, 2024 5:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Acquisition will cost almost $20 million cash out (mostly to advisors) and huge dilution in future to pay for those first dosages of TRIALS! AND the warrants and stock granted. this over tripling is sbdurdly injustigied and will cost very dearly to those who paid north of 10...
AI Kanak
AIKanak Dec 19, 2023 2:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Company does not have working a=capital and reverse split wiill slow down liquidity flow. The comoany is doomed. CEO is saying if reverse split is not appo=roved the company will have to sell its property. Which meens inestors will lose thier money. Beware! investors, AVTX is a junk equity. Period!
AI Kanak
AIKanak Dec 19, 2023 2:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tomorrow if reverse split gets the votes, then its stock is done for. It will tumble like a pillar of sand. Analyst are already rating it for strong sell. You better take your money and run!
Basel haddadin
Basel haddadin Sep 14, 2023 11:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will close at 0.30
SS SS
SS SS Jul 21, 2020 6:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any opinion for CERC ? will go up to 5$ soon ?
SS SS
SS SS Jun 16, 2020 4:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any precious idea what will happen with CERC please ?
Marco Furlan
Marco Furlan Jun 16, 2020 4:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They Will have a virtuale encounter with potential investor on 06/ 01/2022, After tomorrow. They probably Will talk about two new drugs they presented FDA , the result of their studies and FDA position. If everithing Is positive the stock might grow .
Ubaldo Piazza
Ubaldo Piazza Jun 16, 2020 4:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tu che ne pensi sarà positivo o no?
SS SS
SS SS Jun 13, 2020 3:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it worths to entry right now ? what do you think folks ?
Michael Hobson
Michael Hobson Jul 10, 2017 10:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$5 stock by November 15th, 2017
Jeshua Haskins
Jeshua Haskins Jul 10, 2017 10:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Possibly more, if they announce good news in conjunction with the positive news they announced earlier this year with CERC-301. FDA already intends to fast track the approval for the MDD drug.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email